[Effect of HLA compatibility on the transplanted kidney in relation to recipient age]. 1996

D Motzkau, and S Pomer, and P N Bretan, and R Banafsche, and M Wiesel, and G Staehler
Abteilung Urologie der Chirurgischen Universitätsklinik Heidelberg.

Donor-recipient histocompatibility, as evaluated by the HLA matching results, plays an important role in the outcome of renal transplants, although much controversy surrounds the benefit of kidney allocation based on HLA typing. In this report HLA matching and survival data on 1,342 transplants performed at the University of California at San Francisco between 1984 and 1992 and treated uniformly by quadruple immunosuppression were analyzed in relation to the recipient's age. With respect to the influence of the increasing number of mismatches from 0 to 6, the analysis revealed decreasing 3-year graft survival rates as follows: 85.4%; 87.3%; 71.3%; 78.2%; 75.8%; 70.9% and 67.5%. Whereas the impact of cold ischemia time and histocompatibility was equally important during the 3-year postoperative period, the essential positive influence of good HLA matching on the long-term graft survival was demonstrated. The children aged between 5 and 18 years were identified as a high-risk group by the analysis, HLA-A incompatibility being attributed to poor graft survival in this age group. With respect to the effect of HLA-A histoincompatibility, the data provide evidence that HLA-A matching results seem to play an important role in graft survival in children, whereas transplants well matched in terms of HLA-B did well in adult recipients. No age difference in the impact of HLA-DR could be detected. In conclusion, HLA matching is still essential. It seems that there are differences in the impact of HLA loci in relation to the recipient's age.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002102 Cadaver A dead body, usually a human body. Corpse,Cadavers,Corpses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D Motzkau, and S Pomer, and P N Bretan, and R Banafsche, and M Wiesel, and G Staehler
June 1994, Infusionstherapie und Transfusionsmedizin,
D Motzkau, and S Pomer, and P N Bretan, and R Banafsche, and M Wiesel, and G Staehler
February 1994, Transplantation proceedings,
D Motzkau, and S Pomer, and P N Bretan, and R Banafsche, and M Wiesel, and G Staehler
January 1988, Transfusion,
D Motzkau, and S Pomer, and P N Bretan, and R Banafsche, and M Wiesel, and G Staehler
September 1987, The Annals of thoracic surgery,
D Motzkau, and S Pomer, and P N Bretan, and R Banafsche, and M Wiesel, and G Staehler
January 2009, Transplant immunology,
D Motzkau, and S Pomer, and P N Bretan, and R Banafsche, and M Wiesel, and G Staehler
June 1996, Transplantation proceedings,
D Motzkau, and S Pomer, and P N Bretan, and R Banafsche, and M Wiesel, and G Staehler
August 1994, Transplantation proceedings,
D Motzkau, and S Pomer, and P N Bretan, and R Banafsche, and M Wiesel, and G Staehler
January 2010, Clinical transplants,
D Motzkau, and S Pomer, and P N Bretan, and R Banafsche, and M Wiesel, and G Staehler
November 1991, Presse medicale (Paris, France : 1983),
D Motzkau, and S Pomer, and P N Bretan, and R Banafsche, and M Wiesel, and G Staehler
November 1998, Transplantation proceedings,
Copied contents to your clipboard!